Literature DB >> 22918008

The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines.

Zohreh Dalirsani1, Safar Farajnia, Yousef Javadzadeh, Masoumeh Mehdipour, Sepideh Koozegari.   

Abstract

AIM: Oral squamous cell carcinoma (OSCC) is responsible for about 90% of oral malignancies and its incidence is increasing. Despite various treatment protocols, survival rate of OSCC is low. Chemotherapy that is used for treating this carcinoma in advanced stages is systemic therapy that destroys carcinogenic cells, and controls tumor metastasis. Chemotherapy is very toxic and has limitations, especially for patients in advanced stages. Considering positive effects of retinoid and vitamin D3 derivatives in treating some carcinomas, we decided to evaluate the effect of combination of these drugs on OSCC. In this study the effects of combination of 5-fluorouracil, 13-cis retinoic acid and vitamin D3 on cultured cell of OSCC have been evaluated.
MATERIALS AND METHODS: OSCC cells were cultured in culture media and different concentration of 5-fluorouracil, 13-cis retinoic acid and vitamin D3 were added to cultured cell as separately and in combinations. The effect of treatment on cell proliferation and induction of apoptosis were evaluated by MTT and TUNEL assays respectively.
RESULTS: Combination of 5-fluorouracil and 13- cis retinoic acid had the highest inhibitory effect on SCC cell proliferation. Combination of two drugs had more apoptotic effect than each of them separately, and combination of three drugs had more effect than combination of two drugs.
CONCLUSION: Because combination of drugs had more inhibitory effect on cell proliferation than one of them and combination of three drugs had the most apoptotic effect than one of these drugs separately, these drugs may have synergic effect on OSCC. CLINICAL SIGNIFICANCE: Combination of three drugs has more inhibitory effect on cell proliferation and apoptotic effect than one of these drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918008     DOI: 10.5005/jp-journals-10024-1149

Source DB:  PubMed          Journal:  J Contemp Dent Pract        ISSN: 1526-3711


  6 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

2.  1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.

Authors:  Kumaran Sundaram; Yuvaraj Sambandam; Eichi Tsuruga; Carol L Wagner; Sakamuri V Reddy
Journal:  Horm Cancer       Date:  2014-02-05       Impact factor: 3.869

3.  Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.

Authors:  Martin Grimm; Marcel Cetindis; Thorsten Biegner; Max Lehman; Adelheid Munz; Peter Teriete; Siegmar Reinert
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01

4.  Expression of vitamin D receptor and vitamin D status in patients with oral neoplasms and effect of vitamin D supplementation on quality of life in advanced cancer treatment.

Authors:  Akshay Anand; Suyash Singh; Abhinav A Sonkar; Nuzhat Husain; Kul Ranjan Singh; Sudhir Singh; Jitendra K Kushwaha
Journal:  Contemp Oncol (Pozn)       Date:  2017-06-30

5.  Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.

Authors:  Chia Ee Lee; Vui King Vincent-Chong; Anand Ramanathan; Thomas George Kallarakkal; Lee Peng Karen-Ng; Wan Maria Nabillah Ghani; Zainal Ariff Abdul Rahman; Siti Mazlipah Ismail; Mannil Thomas Abraham; Keng Kiong Tay; Wan Mahadzir Wan Mustafa; Sok Ching Cheong; Rosnah Binti Zain
Journal:  Int J Med Sci       Date:  2015-11-01       Impact factor: 3.738

Review 6.  Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity.

Authors:  Kanchanlata Singh; Mustansir Bhori; Yasar Arfat Kasu; Ganapathi Bhat; Thankamani Marar
Journal:  Saudi Pharm J       Date:  2017-12-19       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.